The Multi Targeting Molecule market is a subset of the Drug Discovery industry, which focuses on the development of new drugs to treat a variety of diseases. Multi Targeting Molecules are compounds that interact with multiple targets in the body, allowing for more effective treatments. These molecules are designed to interact with multiple targets simultaneously, allowing for more efficient drug delivery and improved efficacy. Multi Targeting Molecules are used in a variety of therapeutic areas, including oncology, neurology, and cardiovascular diseases.
The Multi Targeting Molecule market is highly competitive, with many companies developing and marketing these compounds. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
